{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:24:33Z","timestamp":1783718673224,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1D1A1B04934590"],"award-info":[{"award-number":["2016R1D1A1B04934590"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI17C0912"],"award-info":[{"award-number":["HI17C0912"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12072-020-10063-9","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T16:06:48Z","timestamp":1592410008000},"page":"798-807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease"],"prefix":"10.1007","volume":"14","author":[{"given":"Jung Nam","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae Kyung","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Kyung","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2926-1007","authenticated-orcid":false,"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"10063_CR1","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","volume":"142","author":"N Chalasani","year":"2012","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012;142:1592\u2013609.","journal-title":"Gastroenterology"},{"key":"10063_CR2","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA 2015;313:2263\u201373.","journal-title":"JAMA"},{"key":"10063_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","volume":"7","author":"N Rafiq","year":"2009","unstructured":"Rafiq N, Bai C, Fang Y, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009;7:234\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10063_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/hep.23314","volume":"51","author":"C Soderberg","year":"2010","unstructured":"Soderberg C, Stal P, Askling J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology 2010;51:595\u2013602.","journal-title":"Hepatology"},{"key":"10063_CR5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/hep.26717","volume":"59","author":"MJ Armstrong","year":"2014","unstructured":"Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology 2014;59:1174\u201397.","journal-title":"Hepatology"},{"key":"10063_CR6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","volume":"64","author":"G Targher","year":"2014","unstructured":"Targher G, Chonchol MB, Byrne CD. CKD and nonalcoholic fatty liver disease. Am J Kidney Dis 2014;64:638\u201352.","journal-title":"Am J Kidney Dis"},{"key":"10063_CR7","doi-asserted-by":"publisher","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","volume":"11","author":"G Musso","year":"2014","unstructured":"Musso G, Gambino R, Tabibian JH, et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med 2014;11:e1001680.","journal-title":"PLoS Med"},{"key":"10063_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00125-007-0897-4","volume":"51","author":"G Targher","year":"2008","unstructured":"Targher G, Bertolini L, Rodella S, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative\/laser-treated retinopathy in type 2 diabetic patients. Diabetologia 2008;51:444\u201350.","journal-title":"Diabetologia"},{"key":"10063_CR9","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00125-010-1720-1","volume":"53","author":"G Targher","year":"2010","unstructured":"Targher G, Bertolini L, Chonchol M, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia 2010;53:1341\u20138.","journal-title":"Diabetologia"},{"key":"10063_CR10","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.2215\/CJN.05050610","volume":"5","author":"G Targher","year":"2010","unstructured":"Targher G, Bertolini L, Rodella S, Lippi G, Zoppini G, Chonchol M. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol 2010;5:2166\u201371.","journal-title":"Clin J Am Soc Nephrol"},{"key":"10063_CR11","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1681\/ASN.2012040390","volume":"23","author":"P Ruggenenti","year":"2012","unstructured":"Ruggenenti P, Cravedi P, Remuzzi G. Mechanisms and treatment of CKD. J Am Soc Nephrol 2012;23:1917\u201328.","journal-title":"J Am Soc Nephrol"},{"key":"10063_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.ki.5000054","volume":"69","author":"Y Liu","year":"2006","unstructured":"Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006;69:213\u20137.","journal-title":"Kidney Int"},{"key":"10063_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nrgastro.2013.138","volume":"10","author":"DM Torres","year":"2013","unstructured":"Torres DM, Harrison SA. NAFLD: Predictive value of ALT levels for NASH and advanced fibrosis. Nat Rev Gastroenterol Hepatol 2013;10:510\u20131.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10063_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/gerona\/glu010","volume":"69","author":"SA Studenski","year":"2014","unstructured":"Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 2014;69:547\u201358.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10063_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, Network NCR. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 2011;53:810\u201320.","journal-title":"Hepatology"},{"key":"10063_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","volume":"64","author":"AS Levey","year":"2014","unstructured":"Levey AS, Inker LA, Matsushita K, et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2014;64:821\u201335.","journal-title":"Am J Kidney Dis"},{"key":"10063_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000452228","volume":"44","author":"JH Hwang","year":"2016","unstructured":"Hwang JH, Lee JP, Kim CT, et al. Urinary periostin excretion predicts renal outcome in IgA nephropathy. Am J Nephrol 2016;44:481\u201392.","journal-title":"Am J Nephrol"},{"key":"10063_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.0006-341X.2001.00114.x","volume":"57","author":"G Heinze","year":"2011","unstructured":"Heinze G, Schemper M. A solution to the problem of monotone likelihood in Cox regression. Biometrics 2011;57:114\u20139.","journal-title":"Biometrics"},{"key":"10063_CR19","doi-asserted-by":"publisher","first-page":"e0142808","DOI":"10.1371\/journal.pone.0142808","volume":"10","author":"G Jia","year":"2015","unstructured":"Jia G, Di F, Wang Q, et al. Non-alcoholic fatty liver disease is a risk factor for the development of diabetic nephropathy in patients with type 2 diabetes mellitus. PLoS One 2015;10:e0142808.","journal-title":"PLoS One"},{"key":"10063_CR20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/jdi.12518","volume":"7","author":"LH Yan","year":"2016","unstructured":"Yan LH, Mu B, Guan Y, et al. Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications. J Diabetes Investig 2016;7:889\u201394.","journal-title":"J Diabetes Investig"},{"key":"10063_CR21","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1681\/ASN.2007101155","volume":"19","author":"G Targher","year":"2008","unstructured":"Targher G, Chonchol M, Bertolini L, et al. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol 2008;19:1564\u201370.","journal-title":"J Am Soc Nephrol"},{"key":"10063_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113\u201321.","journal-title":"Gastroenterology"},{"key":"10063_CR23","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jhep.2017.08.024","volume":"67","author":"DH Sinn","year":"2017","unstructured":"Sinn DH, Kang D, Jang HR, et al. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: a cohort study. J Hepatol 2017;67:1274\u201380.","journal-title":"J Hepatol"},{"key":"10063_CR24","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.1038\/s41598-018-23014-0","volume":"8","author":"HR Jang","year":"2018","unstructured":"Jang HR, Kang D, Sinn DH, et al. Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study. Sci Rep 2018;8:4718.","journal-title":"Sci Rep"},{"key":"10063_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.09.017","author":"BK Koo","year":"2019","unstructured":"Koo BK, An JN, Joo SK, et al. Association between a polymorphism in MBOAT7 and chronic kidney disease in patients with biopsy-confirmed nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2019. https:\/\/doi.org\/10.1016\/j.cgh.2019.09.017.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10063_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jhep.2010.11.007","volume":"54","author":"G Targher","year":"2011","unstructured":"Targher G, Chonchol M, Zoppini G, Abaterusso C, Bonora E. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol 2011;54:1020\u20139.","journal-title":"J Hepatol"},{"key":"10063_CR27","doi-asserted-by":"publisher","first-page":"F1187","DOI":"10.1152\/ajprenal.00425.2014","volume":"307","author":"S Tanaka","year":"2014","unstructured":"Tanaka S, Tanaka T, Nangaku M. Hypoxia as a key player in the AKI-to-CKD transition. Am J Physiol Renal Physiol. 2014;307:F1187\u2013195.","journal-title":"Am J Physiol Renal Physiol"},{"key":"10063_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/ki.2012.439","volume":"83","author":"S Ruiz","year":"2013","unstructured":"Ruiz S, Pergola PE, Zager RA, Vaziri ND. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int 2013;83:1029\u201341.","journal-title":"Kidney Int"},{"key":"10063_CR29","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012;120:c179\u201384.","journal-title":"Nephron Clin Pract"},{"key":"10063_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/CCM.0000000000002012","volume":"45","author":"JN An","year":"2017","unstructured":"An JN, Hwang JH, Kim DK, Lee H, Ahn SY, Kim S, et al. Chronic kidney disease after acute kidney injury requiring continuous renal replacement therapy and its impact on long-term outcomes: a multicenter retrospective cohort study in Korea. Crit Care Med 2017;45:47\u201357.","journal-title":"Crit Care Med"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-020-10063-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-020-10063-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T02:22:16Z","timestamp":1667010136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-020-10063-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10063"],"URL":"https:\/\/doi.org\/10.1007\/s12072-020-10063-9","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"16 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Jung Nam An, Sae Kyung Joo, Bo Kyung Koo, Jung Ho Kim, Sohee Oh and Won Kim do not have any relevant conflict of interest or other financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of Seoul National University Boramae Medical Center (16-2014-86) and was carried out in accordance with the guidelines of the 2013 Declaration of Helsinki. All study participants provided informed consent prior to recruitment into the registry.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}